Literature DB >> 12695921

[Modern treatment options for Zenker's diverticulum: indications and results].

M Colombo-Benkmann1, V Unruh, T Kocher, C Krieglstein, N Senninger.   

Abstract

Conventional transcervical therapy of Zenker's diverticulum comprises diverticulectomy, invagination, diverticulopexy and myotomy, which may be combined with the aforementioned methods. Transoral diverticuloesophagostomy is performed by diathermy, lasers or staplers through a rigid esophagoscope, or more recently by diathermy applied via a flexible endoscope. Morbidity of transcervical procedures ranges between 3 (myotomy) and 23 % (diverticulectomy + myotomy). The percentage of patients with at least significantly improved symptoms is 92 % or more, while recurrences occur in 5.7 (diverticulectomy alone) to 21 % (invagination). Transoral procedures have a morbidity of 9 (stapler) to 26 % (Laser), while symptoms improve in 91 (diathermy through rigid esophagoscope) to 99 % (diathermy via flexible endoscope), however in up to 64 % of patients reoperations are necessary. Small diverticula (Brombart I/II) can be treated by diverticulectomy (with/without myotomy) or flexible endoscopy, larger diverticula in general by all methods. Patients younger than 60 years should undergo diverticulectomy, elderly multimorbid patients should be treated by transoral procedures.

Entities:  

Mesh:

Year:  2003        PMID: 12695921     DOI: 10.1055/s-2003-38528

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  3 in total

1.  Therapy of Zenker's diverticulum.

Authors:  Arnd Vogelsang; Brigitte Schumacher; Horst Neuhaus
Journal:  Dtsch Arztebl Int       Date:  2008-02-15       Impact factor: 5.594

2.  Surgical treatment of hypopharyngeal diverticulum (Zenker's diverticulum).

Authors:  Tilman Keck; Ajnacska Rozsasi; Philipp M Grün
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-08-28       Impact factor: 2.503

3.  Endoscopic Treatment of Zenker's Diverticulum: Comparable Treatment Outcomes in Treatment-Naïve and Pretreated Patients.

Authors:  Johannes Manzeneder; Christoph Römmele; Carolin Manzeneder; Alanna Ebigbo; Helmut Messmann; Stefan Karl Goelder
Journal:  Gastroenterol Res Pract       Date:  2021-03-16       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.